Researchers found a significant increase between 1999 and 2008 compared with astigmatism rates between 1971 and 1975.
The devices decrease refractive astigmatism postoperatively compared with preoperative corneal astigmatism.
Edmund Tsui, MD, social media editor for the American Academy of Ophthalmology’s journal Ophthalmology, guides readers through what’s trend-worthy in eye care.
Patients implanted with foldable iris-fixated phakic intraocular lenses may experience annual changes in refractive error, visual acuity, and axial length, making the devices a long-term, but not permanent solution.
Older age, increased IOP, thinner central cornea, higher vertical cup/disc ratio, and longer axial length were also highly associated with open-angle glaucoma incidence.
Research shows the devices’ effectiveness in patients with high myopia, astigmatism.
The technique also led to faster visual rehabilitation and lower complication rates than single running and interrupted sutures.
Study suggests sharp refractive control in 2-step phacoemulsification plus PRK, but similar outcomes and fewer risks with 1-step toric IOL implantation.
Researchers offer clarity for early intervention in choroideremia with this largest meta-analysis to date.
Clinicians adjusted determination of candidacy for refractive surgery in 16% of participants after viewing corneal epithelial patterns.
Despite significantly prolonging SMILE surgery time, unintended initial dissection of the posterior plane did not affect long-term visual recovery, a report shows.
Foldable phakic intraocular lens produced refractive stability at 15 years, but study advises at least 3 mm anterior chamber depth to implant pIOL.
However, researchers note “clinically relevant differences” in glaucoma procedure success rates for patients with a history of the refractive procedure.
Patients with epiretinal membranes still saw improvements in their vision at various distances after surgery, even if they had prior trifocal implants.
Bilateral refractive lens exchange with trifocal intraocular lens appears to be a safe and effective treatment for presbyopia.
A study shows a statistically significant increase of 0.1 mm in axial length after posterior chamber phakic intraocular lens implantation.
Patients with certain antibodies, those of older age at onset, and men are more likely to have worse outcomes.
A study shows the approach’s safety and efficacy is comparable to muscle recession.
The surgical approach was well-tolerated and reduced the angle of esotropia, the study shows.
The technology was reliable for these patients, except for trefoil, the study shows.